ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Anti-Interferon Alpha Antibodies in Patients with High-Risk BCR/ABL-Negative Myeloproliferative Neoplasms Treated with Recombinant Human Interferon-α.

Aruna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.